|
1
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nat Rev Cancer. 13:123–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Takahashi S, Tasaka A, Yoshima T,
Ochi H and Chayama K: Involvement of microRNA-224 in cell
proliferation, migration, invasion, and anti-apoptosis in
hepatocellular carcinoma. J Gastroenterol Hepatol. 28:565–575.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao C, Li Y, Zhang M, Yang Y and Chang L:
miR-126 inhibits cell proliferation and induces cell apoptosis of
hepatocellular carcinoma cells partially by targeting Sox2. Hum
Cell. 28:91–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He C, Dong X, Zhai B, Jiang X, Dong D, Li
B, Jiang H, Xu S and Sun X: MiR-21 mediates sorafenib resistance of
hepatocellular carcinoma cells by inhibiting autophagy via the
PTEN/Akt pathway. Oncotarget. 6:28867–28881. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi J, Wu X, Surma M, Vemula S, Zhang L,
Yang Y, Kapur R and Wei L: Distinct roles for ROCK1 and ROCK2 in
the regulation of cell detachment. Cell Death Dis. 4:e4832013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kümper S, Mardakheh FK, McCarthy A, Yeo M,
Stamp GW, Paul A, Worboys J, Sadok A, Jørgensen C, Guichard S and
Marshall CJ: Rho-associated kinase (ROCK) function is essential for
cell cycle progression, senescence and tumorigenesis. Elife.
5:e129942016. View Article : Google Scholar :
|
|
7
|
Julian L and Olson MF: Rho-associated
coiled-coil containing kinases (ROCK): Structure, regulation, and
functions. Small GTPases. 5:e298462014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schofield AV, Steel R and Bernard O:
Rho-associated coiled-coil kinase (ROCK) protein controls
microtubule dynamics in a novel signaling pathway that regulates
cell migration. J Biol Chem. 287:43620–43629. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong CC, Wong CM, Tung EK, Man K and Ng
IO: Rho-kinase 2 is frequently overexpressed in hepatocellular
carcinoma and involved in tumor invasion. Hepatology. 49:1583–1594.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Molnár A, Schwach F, Studholme DJ,
Thuenemann EC and Baulcombe DC: miRNAs control gene expression in
the single-cell alga Chlamydomonas reinhardtii. Nature.
447:1126–1129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin L, Gan H, Zhang H, Tang W, Sun Y, Tang
X, Kong D, Zhou J, Wang Y and Zhu Y: MicroRNA-21 inhibits SMAD7
expression through a target sequence in the 3′ untranslated region
and inhibits proliferation of renal tubular epithelial cells. Mol
Med Rep. 10:707–712. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fong MY, Zhou W, Liu L, Alontaga AY,
Chandra M, Ashby J, Chow A, O'Connor ST, Li S, Chin AR, et al:
Breast-cancer-secreted miR-122 reprograms glucose metabolism in
premetastatic niche to promote metastasis. Nat Cell Biol.
17:183–194. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y and
Zheng X: miR-34a inhibits migration and invasion by down-regulation
of c-Met expression in human hepatocellular carcinoma cells. Cancer
lett. 275:44–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li B, Huang P, Qiu J, Liao Y, Hong J and
Yuan Y: MicroRNA-130a is down-regulated in hepatocellular carcinoma
and associates with poor prognosis. Med Oncol. 31:2302014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun T, Fu J, Shen T, Lin X, Liao L, Feng
XH and Xu J: The small C-terminal domain phosphatase 1 inhibits
cancer cell migration and invasion by dephosphorylating
Ser(P)68-twist1 to accelerate twist1 protein degradation. J Biol
Chem. 291:11518–11528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clavien PA, Lesurtel M, Bossuyt PM, Gores
GJ, Langer B and Perrier A: OLT for HCC Consensus Group:
Recommendations for liver transplantation for hepatocellular
carcinoma: An international consensus conference report. Lancet
Oncol. 13:e11–e22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Giordano S and Columbano A: MicroRNAs: New
tools for diagnosis, prognosis, and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Acunzo M, Visone R, Romano G, Veronese A,
Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli
G, et al: miR-130a targets MET and induces TRAIL-sensitivity in
NSCLC by downregulating miR-221 and 222. Oncogene. 31:634–642.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen S, Guo X, Yan H, Lu Y, Ji X, Li L,
Liang T, Zhou D, Feng XH, Zhao JC, et al: A miR-130a-YAP positive
feedback loop promotes organ size and tumorigenesis. Cell Res.
25:997–1012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsuoka T and Yashiro M: Rho/ROCK
signaling in motility and metastasis of gastric cancer. World J
Gastroenterol. 20:13756–13766. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vigil D, Kim TY, Plachco A, Garton AJ,
Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, Campbell SL and
Der CJ: ROCK1 and ROCK2 are required for non-small cell lung cancer
anchorage-independent growth and invasion. Cancer Res.
72:5338–5347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu T, Yu X, Li G, Yuan R, Wang Q, Tang P,
Wu L, Liu X, Peng X and Shao J: Rock2 regulates Cdc25A through
ubiquitin proteasome system in hepatocellular carcinoma cells. Exp
Cell Res. 318:1994–2003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang W, Zhou X and Wei M: MicroRNA-144
suppresses osteosarcoma growth and metastasis by targeting ROCK1
and ROCK2. Oncotarget. 6:10297–10308. 2015.PubMed/NCBI
|
|
26
|
Huang D, Du X, Yuan R, Chen L, Liu T, Wen
C, Huang M, Li M, Hao L and Shao J: Rock2 promotes the invasion and
metastasis of hepatocellular carcinoma by modifying MMP2
ubiquitination and degradation. Biochem Biophys Res Commun.
453:49–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kroiss A, Vincent S, Decaussin-Petrucci M,
Meugnier E, Viallet J, Ruffion A, Chalmel F, Samarut J and Allioli
N: Androgen-regulated microRNA-135a decreases prostate cancer cell
migration and invasion through downregulating ROCK1 and ROCK2.
Oncogene. 34:2846–2855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Boll K, Reiche K, Kasack K, Mörbt N,
Kretzschmar AK, Tomm JM, Verhaegh G, Schalken J, Von Bergen M, Horn
F and Hackermüller J: MiR-130a, miR-203 and miR-205 jointly repress
key oncogenic pathways and are downregulated in prostate carcinoma.
Oncogene. 32:277–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
